Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price rose 4.5% on Tuesday . The company traded as high as $1.84 and last traded at $1.84. Approximately 162,971 shares traded hands during trading, an increase of 143% from the average daily volume of 67,097 shares. The stock had previously closed at $1.76.
Cardiol Therapeutics Stock Up 4.5 %
The stock’s fifty day simple moving average is $1.70 and its two-hundred day simple moving average is $1.20.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Read More
- Five stocks we like better than Cardiol Therapeutics
- Overbought Stocks Explained: Should You Trade Them?
- Hasbro’s Management Made All the Right Calls This Quarter
- What Investors Need to Know About Upcoming IPOs
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Options Trading – Understanding Strike Price
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
